We believe that every person deserves an equal chance to lead a healthy life.
This begins with access to effective and affordable medicines, wherever they are needed.
LenioBio is a life sciences biotech company, pioneering a disruptive protein expression platform.
Using our ALiCE technology, we enable our customers – researchers and biopharma manufacturers -to streamline and accelerate their protein discovery, development, and production processes.
We aim to simplify manufacturing and speed up the delivering drugs to the patient.
Lenio, which derives from Latin, means “to ease, alleviate, make better”
Embarking on a remarkable journey, our story finds its roots during the 2015 Ebola pandemic.
Driven by an unwavering commitment to address urgent demands for essential medicines, we are dedicated to making a profound impact on global health and well-being.
Today, our customized protein service and cell-free lysate products empower academic, biotech, and pharma customers worldwide to conquer their protein production challenges. See how we got to where we are today…
We are an international group of scientists and business experts, committed to pushing the boundaries of protein science further to improve the everyday for 8 billion of us.
As a company, we recognize the importance of social responsibility and the role it plays in building a sustainable future for all. We believe that it is our duty to not only operate in an ethical and environmentally conscious manner but also to actively give back to our community and society as a whole.
At Leniobio, we are committed to making a positive impact in the world by supporting various social causes and initiatives. We understand that our success is directly tied to the well-being of the communities we serve, and we strive to be a responsible corporate citizen at all times.